We are live on ! Find out more
CVS icon

CVS Health

1,972 hedge funds and large institutions have $68.1B invested in CVS Health in 2020 Q4 according to their latest regulatory filings, with 277 funds opening new positions, 842 increasing their positions, 720 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

195% more first-time investments, than exits

New positions opened: 277 | Existing positions closed: 94

38% more call options, than puts

Call options by funds: $1.88B | Put options by funds: $1.36B

30% more funds holding in top 10

Funds holding in top 10: 4660 (+14)

17% more capital invested

Capital invested by funds: $58.2B → $68.1B (+$9.97B)

17% more repeat investments, than reductions

Existing positions increased: 842 | Existing positions reduced: 720

9% more funds holding

Funds holding: 1,8151,972 (+157)

0.1% less ownership

Funds ownership: 76.22%76.12% (-0.1%)

Holders
1,972
Holders Change
+157
Holders Change %
+8.65%
% of All Funds
34.9%
Holding in Top 10
60
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+30.43%
% of All Funds
1.06%
New
277
Increased
842
Reduced
720
Closed
94
Calls
$1.88B
Puts
$1.36B
Net Calls
+$523M
Net Calls Change
-$123M
Name Holding Trade Value Shares
Change
Change in
Stake
PA
326
Pinnacle Associates
New York
$14.1M +$513K +7,894 +4%
GIP
327
Greatmark Investment Partners
Georgia
$14M -$80.9K -1,244 -0.6%
FWIA
328
Fort Washington Investment Advisors
Ohio
$14M +$27.4K +422 +0.2%
CG
329
Colony Group
Massachusetts
$13.9M -$4.51M -69,355 -25%
BS
330
Banco Santander
Spain
$13.9M +$2.73M +41,912 +26%
Calamos Advisors
331
Calamos Advisors
Illinois
$13.9M -$477K -7,334 -3%
Jane Street
332
Jane Street
New York
$13.7M +$639K +9,832 +5%
OAM
333
Oppenheimer Asset Management
New York
$13.6M -$2.24M -34,391 -15%
TAM
334
Trillium Asset Management
Massachusetts
$13.5M +$149K +2,290 +1%
SPIA
335
Steward Partners Investment Advisory
New York
$13.4M +$997K +15,325 +8%
Group One Trading
336
Group One Trading
Illinois
$13.3M -$1.74M -26,761 -12%
FBP
337
Flippin Bruce & Porter
Virginia
$13.1M -$297K -4,562 -2%
Impax Asset Management Group
338
Impax Asset Management Group
United Kingdom
$12.9M +$9.98M +153,408 +426%
PAG
339
Private Advisor Group
New Jersey
$12.9M +$4.22M +64,870 +52%
BCM
340
Bourgeon Capital Management
Connecticut
$12.8M +$6.05K +93 +0%
NIPH
341
NN Investment Partners Holdings
Netherlands
$12.6M -$2.28M -35,125 -16%
DnB Asset Management
342
DnB Asset Management
Norway
$12.6M +$64.3K +989 +0.5%
MOACM
343
Mutual of America Capital Management
New York
$12.6M -$430K -6,617 -3%
Man Group
344
Man Group
United Kingdom
$12.5M -$7.32M -112,607 -38%
CB
345
Commerce Bank
Missouri
$12.5M -$269K -4,129 -2%
GH
346
GAM Holding
Switzerland
$12.4M +$741K +11,392 +7%
MSA
347
Mason Street Advisors
Wisconsin
$12.3M -$211K -3,249 -2%
H
348
Hexavest
Quebec, Canada
$12.2M -$6.43M -98,908 -36%
VCAM
349
Van Cleef Asset Management
Ohio
$12.1M +$85.3K +1,311 +0.7%
LIA
350
LS Investment Advisors
Michigan
$12.1M -$91.7K -1,410 -0.8%

CVS Hedge Fund Activity: Q4 2020 in Review

1,972 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2020, worth a combined $68.1B — up 17% from $58.2B a quarter earlier.

Buyers outnumbered sellers: 277 funds opened new CVS positions and 94 closed out — a net gain of 183 holders — while 842 added to existing stakes and 720 trimmed.

The largest buyer was Capital International Investors, adding an estimated $272M. The largest seller was BlackRock, cutting an estimated $508M.

  • 1,972 institutional investors held CVS Health (CVS) as of Q4 2020, up from 1,815 in Q3 2020.
  • Funds reported $68.1B of CVS Health stock for Q4 2020, up 17% quarter-over-quarter.
  • 277 funds opened new CVS Health positions in Q4 2020 and 94 closed out, a net change of +183 holders.
  • The largest CVS Health buyer in Q4 2020 was Capital International Investors, an estimated $272M added.
  • The largest CVS Health seller in Q4 2020 was BlackRock, an estimated $508M sold.

Based on aggregated 13F filings for Q4 2020.